Creative Planning increased its position in UnitedHealth Group Inc. (NYSE:UNH) by 19.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 39,862 shares of the healthcare conglomerate’s stock after buying an additional 6,447 shares during the period. Creative Planning’s holdings in UnitedHealth Group were worth $5,581,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Van Hulzen Asset Management LLC acquired a new position in shares of UnitedHealth Group during the second quarter worth approximately $104,000. Archford Capital Strategies LLC boosted its position in shares of UnitedHealth Group by 669.2% in the second quarter. Archford Capital Strategies LLC now owns 800 shares of the healthcare conglomerate’s stock worth $113,000 after buying an additional 696 shares during the last quarter. Hanson McClain Inc. boosted its position in shares of UnitedHealth Group by 0.4% in the second quarter. Hanson McClain Inc. now owns 895 shares of the healthcare conglomerate’s stock worth $126,000 after buying an additional 4 shares during the last quarter. Howe & Rusling Inc. boosted its position in shares of UnitedHealth Group by 4.5% in the second quarter. Howe & Rusling Inc. now owns 920 shares of the healthcare conglomerate’s stock worth $130,000 after buying an additional 40 shares during the last quarter. Finally, Parkside Financial Bank & Trust boosted its position in shares of UnitedHealth Group by 31.4% in the second quarter. Parkside Financial Bank & Trust now owns 996 shares of the healthcare conglomerate’s stock worth $140,000 after buying an additional 238 shares during the last quarter. 84.92% of the stock is owned by institutional investors.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Shares of UnitedHealth Group Inc. (NYSE:UNH) traded down 0.46% on Monday, reaching $152.11. 5,023,579 shares of the company were exchanged. The stock has a market capitalization of $144.61 billion, a price-to-earnings ratio of 25.31 and a beta of 0.63. The firm’s 50 day moving average price is $143.37 and its 200 day moving average price is $139.61. UnitedHealth Group Inc. has a 52 week low of $107.51 and a 52 week high of $154.50.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 18th. The healthcare conglomerate reported $2.17 EPS for the quarter, beating the Zacks’ consensus estimate of $2.08 by $0.09. UnitedHealth Group had a net margin of 3.62% and a return on equity of 19.92%. The company had revenue of $46.30 billion for the quarter, compared to analysts’ expectations of $46.09 billion. During the same quarter in the prior year, the company posted $1.77 earnings per share. UnitedHealth Group’s revenue for the quarter was up 11.6% compared to the same quarter last year. Equities research analysts anticipate that UnitedHealth Group Inc. will post $8.01 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 13th. Shareholders of record on Friday, December 2nd will be given a $0.625 dividend. The ex-dividend date of this dividend is Wednesday, November 30th. This represents a $2.50 dividend on an annualized basis and a yield of 1.64%. UnitedHealth Group’s payout ratio is currently 36.93%.

WARNING: This piece of content was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece of content on another domain, it was copied illegally and republished in violation of international trademark and copyright law. The original version of this piece of content can be read at https://www.thecerbatgem.com/2016/11/28/unitedhealth-group-inc-unh-shares-bought-by-creative-planning.html.

A number of research firms have issued reports on UNH. Leerink Swann restated a “buy” rating on shares of UnitedHealth Group in a research report on Wednesday, November 23rd. Mizuho cut shares of UnitedHealth Group from a “buy” rating to a “neutral” rating in a research report on Wednesday, November 9th. Credit Suisse Group AG restated an “outperform” rating and issued a $160.00 price objective (up previously from $155.00) on shares of UnitedHealth Group in a research report on Friday, October 21st. Vetr cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $144.66 price objective on the stock. in a research report on Tuesday, October 18th. Finally, Jefferies Group restated a “buy” rating and issued a $163.00 price objective on shares of UnitedHealth Group in a research report on Sunday, October 16th. Two analysts have rated the stock with a hold rating and twenty-two have given a buy rating to the company’s stock. UnitedHealth Group currently has an average rating of “Buy” and a consensus target price of $158.03.

In other UnitedHealth Group news, Director Kenneth Irwin Shine sold 325 shares of the company’s stock in a transaction dated Friday, October 21st. The shares were sold at an average price of $144.99, for a total value of $47,121.75. Following the transaction, the director now owns 28,613 shares of the company’s stock, valued at $4,148,598.87. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Gail R. Wilensky sold 5,460 shares of the company’s stock in a transaction dated Thursday, November 17th. The shares were sold at an average price of $150.55, for a total transaction of $822,003.00. Following the completion of the transaction, the director now directly owns 60,052 shares in the company, valued at approximately $9,040,828.60. The disclosure for this sale can be found here. 1.65% of the stock is currently owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

5 Day Chart for NYSE:UNH

Receive News & Stock Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related stocks with our FREE daily email newsletter.